CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Open-market buy Sr. VP, Drug Development bought 10,000 shares at $2.84 ($28,434)
- 4 Open-market buy 10% owner bought 20,000 shares at $2.88 ($57,600)
- 4 Open-market buy Director bought 20,000 shares at $2.88 ($57,600)
- 4 Open-market buy President and CEO bought 20,000 shares at an average $2.85 ($57,009)
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 16,806 shares (grant or award)
- 4 Grant or award Director acquired 16,806 shares (grant or award)
- 4 Grant or award Director acquired 4,201 shares (grant or award)
- 4 Grant or award Director acquired 8,403 shares (grant or award)
- 8-K Event Executive or director change
- 8-K Event Agreement ended
- ARS Other Annual Report to Security Holders
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 54 of 62 · 1,224 filings